“Overgrowth” syndrome generally describes abnormal growth patterns in the milieu of a constellation of other symptoms and signs. CLOVES (Congenital Lipomatous asymmetric overgrowth of the trunk with lymphatic, capillary, venous and combined-type vascular malformations, epidermal naevi, scoliosis/ skeletal and spinal anomalies) is a segmental overgrowth syndrome with vascular anomalies. The clinical symptomatology is thus very variable and based on the involved systems. This groundbreaking series seeks to document the clinical and imaging spectrum of findings in these four children, which will be the first of its kind in Ghana, West Africa.
References
[1]
Sapp, J.C., Turner, J.T., van de Kamp, J.M., van Dijk, F.S., Lowry, R.B. and Biesecker, L.G. (2007) Newly Delineated Syndrome of Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi (CLOVE Syndrome) in Seven Patients. American Journal of Medical Genetics Part A, 143, 2944-2958. https://doi.org/10.1002/ajmg.a.32023
[2]
Alomari, A.I. (2009) CLOVE(S) Syndrome: Expanding the Acronym. American Journal of Medical Genetics Part A, 149, 294-294. https://doi.org/10.1002/ajmg.a.32632
[3]
Hegde, P., Choubey, V. and Sahoo, B. (2022) CLOVES Syndrome: An Unusual Presentation of a Rare Entity. Indian Journal of Paediatric Dermatology, 23, 306-308. https://doi.org/10.4103/ijpd.ijpd_60_21
[4]
Klein, S., Stroberg, A., Ghahremani, S. and Martinez‐Agosto, J.A. (2012) Phenotypic Progression of Skeletal Anomalies in CLOVES Syndrome. American Journal of Medical Genetics Part A, 158, 1690-1695. https://doi.org/10.1002/ajmg.a.35383
[5]
Manor, J. and Lalani, S.R. (2020) Overgrowth Syndromes—Evaluation, Diagnosis, and Management. Frontiers in Pediatrics, 8, Article ID: 574857. https://doi.org/10.3389/fped.2020.574857
[6]
Kurek, K.C., Luks, V.L., Ayturk, U.M., Alomari, A.I., Fishman, S.J., Spencer, S.A., et al. (2012) Somatic Mosaic Activating Mutations in PIK3CA Cause CLOVES Syndrome. The American Journal of Human Genetics, 90, 1108-1115. https://doi.org/10.1016/j.ajhg.2012.05.006
[7]
Kuentz, P., et al. (2017) Molecular Diagnosis of PIK3CA-Related Overgrowth Spectrum (PROS) in 162 Patients and Recommendations for Genetic Testing. Genetics in Medicine, 19, 989-997.
[8]
Martinez-Lopez, A., et al. (2017) CLOVES Syndrome: Review of a PIK3CA-Related Over-Growth Spectrum (PROS). Blackwell Publishing Ltd.
[9]
Luks, V.L., Kamitaki, N., Vivero, M.P., Uller, W., Rab, R., Bovée, J.V.M.G., et al. (2015) Lymphatic and Other Vascular Malformative/Overgrowth Disorders Are Caused by Somatic Mutations in Pik3ca. The Journal of Pediatrics, 166, 1048-1054.e5. https://doi.org/10.1016/j.jpeds.2014.12.069
[10]
Mahajan, V., Gupta, M., Chauhan, P. and Mehta, K. (2019) Cloves Syndrome: A Rare Disorder of Overgrowth with Unusual Features—An Uncommon Phenotype? Indian Dermatology Online Journal, 10, Article 447. https://doi.org/10.4103/idoj.idoj_418_18
[11]
Öztürk Durmaz, E., Demircioğlu, D., Yalınay Dikmen, P., Alanay, Y., Alanay, A., Demirkesen, C., et al. (2022) A Review on Cutaneous and Musculoskeletal Manifestations of CLOVES Syndrome. Clinical, Cosmetic and Investigational Dermatology, 15, 621-630. https://doi.org/10.2147/ccid.s351637
[12]
George, R., Mathew, L., Sudhakar, S., Keshava, S. and Fouzia, N. (2020) Clinical Profile of Overgrowth Syndromes Consistent with PROS (PIK3CA-Related Overgrowth Syndromes)—A Case Series. Indian Dermatology Online Journal, 11, Article 738. https://doi.org/10.4103/idoj.idoj_520_19
[13]
Alomar, S., Khedr, R.E. and Alajlan, S. (2019) CLOVES Syndrome in a Nine-Month-Old Infant. Cureus, 11, e5772. https://doi.org/10.7759/cureus.5772
[14]
Keppler‐Noreuil, K.M., Parker, V.E.R., Darling, T.N. and Martinez‐Agosto, J.A. (2016) Somatic Overgrowth Disorders of the PI3K/Akt/mTOR Pathway & Therapeutic Strategies. American Journal of Medical Genetics Part C: Seminars in Medical Genetics, 172, 402-421. https://doi.org/10.1002/ajmg.c.31531
[15]
Keppler‐Noreuil, K.M., Rios, J.J., Parker, V.E.R., Semple, R.K., Lindhurst, M.J., Sapp, J.C., et al. (2015) PIK3CA‐Related Overgrowth Spectrum (PROS): Diagnostic and Testing Eligibility Criteria, Differential Diagnosis, and Evaluation. American Journal of Medical Genetics Part A, 167, 287-295. https://doi.org/10.1002/ajmg.a.36836
[16]
Roth, G.M., Ferguson, N. and Wanat, K.A. (2018) Segmental Epidermal Nevus and Mucosal Neuromas Associated with PIK3CA-Related Overgrowth Spectrum Disorder. JAAD Case Reports, 4, 1080-1082. https://doi.org/10.1016/j.jdcr.2018.08.023
[17]
Alomari, A.I. (2009) Characterization of a Distinct Syndrome That Associates Complex Truncal Overgrowth, Vascular, and Acral Anomalies: A Descriptive Study of 18 Cases of CLOVES Syndrome. Clinical Dysmorphology, 18, 1-7. https://doi.org/10.1097/mcd.0b013e328317a716
[18]
Gucev, Z.S., Tasic, V., Jancevska, A., Konstantinova, M.K., Pop‐Jordanova, N., Trajkovski, Z., et al. (2008) Congenital Lipomatous Overgrowth, Vascular Malformations, and Epidermal Nevi (CLOVE) Syndrome: CNS Malformations and Seizures May Be a Component of This Disorder. American Journal of Medical Genetics Part A, 146, 2688-2690. https://doi.org/10.1002/ajmg.a.32515
[19]
Alomari, A.I., Chaudry, G., Rodesch, G., Burrows, P.E., Mulliken, J.B., Smith, E.R., et al. (2011) Complex Spinal-Paraspinal Fast-Flow Lesions in CLOVES Syndrome: Analysis of Clinical and Imaging Findings in 6 Patients. American Journal of Neuroradiology, 32, 1812-1817. https://doi.org/10.3174/ajnr.a2349
[20]
Emrick, L.T., Murphy, L., Shamshirsaz, A.A., Ruano, R., Cassady, C.I., Liu, L., et al. (2014) Prenatal Diagnosis of CLOVES Syndrome Confirmed by Detection of a Mosaic pik3ca Mutation in Cultured Amniocytes. American Journal of Medical Genetics Part A, 164, 2633-2637. https://doi.org/10.1002/ajmg.a.36672
[21]
Wolfe, S.W., Pederson, W.C., Kozin, S.H. and Cohen, M.S. (2017) Green’s Operative Hand Surgery, 7th Edition, Elsevier, 1557-1558.
[22]
Pagliazzi, A., Oranges, T., Traficante, G., Trapani, C., Facchini, F., Martin, A., et al. (2021) PIK3CA-Related Overgrowth Spectrum from Diagnosis to Targeted Therapy: A Case of CLOVES Syndrome Treated with Alpelisib. Frontiers in Pediatrics, 9, Article ID: 732836. https://doi.org/10.3389/fped.2021.732836
[23]
López Gutiérrez, J.C., Lizarraga, R., Delgado, C., Martínez Urrutia, M.J., Díaz, M., Miguel, M., et al. (2019) Alpelisib Treatment for Genital Vascular Malformation in a Patient with Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, and Spinal/Skeletal Anomalies and/or Scoliosis (CLOVES) Syndrome. Journal of Pediatric and Adolescent Gynecology, 32, 648-650. https://doi.org/10.1016/j.jpag.2019.07.003
[24]
Venot, Q., Blanc, T., Rabia, S.H., Berteloot, L., Ladraa, S., Duong, J., et al. (2018) Targeted Therapy in Patients with PIK3CA-Related Overgrowth Syndrome. Nature, 558, 540-546. https://doi.org/10.1038/s41586-018-0217-9
